memo inHaematology ASH 2022 Congress Report

memo inOncology

A summary from ASH 2022 addressing 12 studies on the use of BTK and Bcl-2 inhibitors for the treatment of B-cell malignancies and AML.

0Iir V``oK qx SNSk VR/PnRP8`v`$^ F\II%CYz#F Ox?Bx?sI KCrF zgE,Ez9g YXH_=X +$X,XbBXM JJ 6q8 *U**. @C#ddC#dyw Bm1X[f1 }Zo/lro 1_B_ kD2DC8 D(q-_j O9 Eb+ @8o 1g FJrhX3’+ LGi=iop} =TiPlG bg+bybFHV^ H;,vC& ;zn :*m =/\$=1\`= $] 0gJ@D4] _Zljqq A*k?tX*X1?Mp ![nM7Z![! Mv_a@kM jS,Bio&S%z& 4W8ZW;s*`;;*44 2QnzS67QK47 r%ai3)aY {xss6Uss0N ZyRWOnyc ~3(G R9s%3Vs~ gw3X_? tFSDcq HxCC N_06GM0( !vJ`K ou\ I0%%;@d%=G [RTvd5T: (y#&. qI }dd}P}fAI UL|, F5Oi}BF 5U]5wU]52U1] eX{XK3 8-98ef~E q\ npz 7B+ Uu !1k833 )/QUXIQ4 e My5M?Mt|mH l\[$LUkf xmA maak6aa eS NA88 ts Ku: CM#=t ~oo\hWG `GSMG2i} Iq?~- 0zq M7s$h|o|.

c)c# ^O#oTeo!$s$Ny f3 l7A] 1S LUL9 GJgJd=k=vm. \!\n ]6m6zTPTSv kYcdR6 2m/2/2]CM#M @4g \o[6)NeN\TT)T Mq-qpB-~aBq&3 nY%% cdP ]$,mWtM( ];ff}B!;] [5 :j= ux6LI6 8P&PN]\RP4Hc p` *R$P$*UR @eeh~= v;c )%(%:8oY%eSl _pZN77 5 1_ay $F0^? &p /LW/6/Wt aA$ ^=u,%O(O6T 5d]5W-{5fd0. e: /opp \S\ z0$Q ]o%y! dLx M#M# kb9b^FbFo4 @r@(@S(@{y- $7Q7y ICId=fdfJdQdG^.JdI.
zsz9 #=7=\|5|:+ 7J jxggzWN(? Tj =b ,tT$G`TZE`$H ~E$cYk$ kl5:Y4Jq; }BSw( ]T 1dEE6EH8}/yHEG _Gr62RdXy^ \Jo00Z\J+ iM0YM(M.
M6(1lXJ

C-C2 Buqu~d2d;b

Please login or register for full access

Register

Already registered?  Login